Ovarian Reserve in Patients With Psoriasis

NCT03492632 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 72

Last updated 2018-07-06

No results posted yet for this study

Summary

Psoriasis is a common autoimmune disease. It affects women of all ages including reproductive years. Autoimmune diseases including psoriasis are linked to premature ovarian reserve. This study aims to measure serum hormones including FSH,LH,E2,PRL and AMH (indicators of ovarian reserve) in women with and without psoriasis.

Conditions

  • Psoriasis
  • Anti Mullerian Hormone
  • Ovarian Reserve

Interventions

OTHER

Hormone panel

Blood sampling on the 3rd day of menstrual cycle for the measurement of serum FSH,LH,PRL,E2 and AMH hormone levels.

Sponsors & Collaborators

  • Kanuni Sultan Suleyman Training and Research Hospital

    lead OTHER

Principal Investigators

  • Berna Aslan Cetin, MD · Kanuni Sultan Suleyman Research and Training Hospital

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-25
Primary Completion
2018-06-30
Completion
2018-07-03

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03492632 on ClinicalTrials.gov